Anster Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-01-2025
- Paid Up Capital ₹ 0.10 M
as on 10-01-2025
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2019
- Revenue 16.81%
(FY 2017)
- Profit 352.39%
(FY 2017)
- Ebitda 22.33%
(FY 2017)
- Net Worth 93.58%
(FY 2017)
- Total Assets 29.30%
(FY 2017)
About Anster Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prashant Bhalgat and Leena Puri serve as directors at the Company.
- CIN/LLPIN
U24110MH2014PTC254228
- Company No.
254228
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2014
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anster Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Bhalgat  | Director | 27-May-2014 | Current |
| Leena Puri | Director | 13-Mar-2014 | Current |
Financial Performance of Anster Pharmaceuticals.
Anster Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 16.81% increase. The company also saw a substantial improvement in profitability, with a 352.39% increase in profit. The company's net worth Soared by an impressive increase of 93.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anster Pharmaceuticals?
In 2017, Anster Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Drtherapeutics International Pharmaceuticals Private LimitedActive 6 years 10 months
Leena Puri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anster Pharmaceuticals?
Unlock and access historical data on people associated with Anster Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anster Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anster Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
